ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Frequently asked questions
What sector does ObsEva SA (OBSEF) operate in?
ObsEva SA belongs to the Other sector and operates in the Biotechnology industry.
What is ObsEva SA (OBSEF) current stock price?
As of the latest data, ObsEva SA stock price is $0.00, with a previous close of $0.00.
What is ObsEva SA (OBSEF) current market capitalization?
ObsEva SA market cap is approximately 11.72 thousand.
What is ObsEva SA (OBSEF) Earnings Per Share (EPS)?
The trailing EPS is -$3.24.
Does ObsEva SA (OBSEF) pay dividends?
No. ObsEva SA does not pay a dividend.
What is ObsEva SA (OBSEF) beta (volatility) score?
ObsEva SA has a beta of 19.646, indicating very high volatility compared to the market.